Disruptions in the realm of medical science

per Rathmell, W. Kimryn
Publicat a J Clin Invest (2020)

VHL Inactivation in Renal Cell Carcinoma: Implications for Diagnosis, Prognosis, and Treatment

per Rathmell, W. Kimryn, Chen, Shufen
Publicat 2008

Systematic Review: ClearCode 34 – A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)

per Ghatalia, Pooja, Rathmell, W. Kimryn
Publicat a Kidney Cancer (2018)

The 2019 Nobel Prize honors fundamental discoveries in hypoxia response

per Moslehi, Javid, Rathmell, W. Kimryn
Publicat a J Clin Invest (2019)

Identification of Ror2 as a Hypoxia-inducible Factor Target in von Hippel-Lindau-associated Renal Cell Carcinoma

per Wright, Tricia M., Rathmell, W. Kimryn
Publicat 2010

Using Molecular Biology to Develop Drugs for Renal Cell Carcinoma

per Cowey, C. Lance, Rathmell, W. Kimryn
Publicat 2008

Renal Cell Carcinoma: Where Will the State-of-the-Art Lead Us?

per Brannon, A. Rose, Rathmell, W. Kimryn
Publicat 2010

Recent Updates in Renal Cell Carcinoma

per Rathmell, W. Kimryn, Godley, Paul A
Publicat 2010

VHL Gene Mutations in Renal Cell Carcinoma: Role as a Biomarker of Disease Outcome and Drug Efficacy

per Cowey, C. Lance, Rathmell, W. Kimryn
Publicat 2009

Emerging molecular classification in RCC: implications for drug development

per Hacker, Kathryn E., Rathmell, W. Kimryn
Publicat 2010

Seeing the forest for the trees: kidney oncogenomes relate to therapeutic outcomes

per Chism, David D., Rathmell, W. Kimryn
Publicat 2014

Rest Assured, much can be learned from adjuvant studies in renal cancer

per Chism, David D., Rathmell, W. Kimryn
Publicat a Nat Rev Nephrol (2016)

A tale of two cancers: Complete genetic analysis of chromophobe renal cell carcinoma contrasts with clear cell renal cell carcinoma

per Fahey, Catherine C, Rathmell, W Kimryn
Publicat a Mol Cell Oncol (2015)

Renal Cancer Subtypes: Should We Be Lumping or Splitting for Therapeutic Decision Making?

per Haake, Scott M., Rathmell, W. Kimryn
Publicat a Cancer (2016)

Untangling ccRCC prognosis with SLINKY

per Reinfeld, Bradley I., Rathmell, W. Kimryn
Publicat a Oncotarget (2017)

COVID-19 impact on early career investigators: a call for action

per Levine, Ross L., Rathmell, W. Kimryn
Publicat a Nat Rev Cancer (2020)

Beyond Glycolysis: Hypoxia Signaling as a Master Regulator of Alternative Metabolic Pathways and the Implications in Clear Cell Renal Cell Carcinoma

per Bacigalupa, Zachary A., Rathmell, W. Kimryn
Publicat a Cancer Lett (2020)

Pushing the boundaries with collision collaboration: the marriage of ideas

per Rathmell, Jeffrey C., Rathmell, W. Kimryn
Publicat a J Clin Invest (2021)

Renal cell carcinoma

per Jonasch, Eric, Gao, Jianjun, Rathmell, W Kimryn
Publicat a BMJ (2014)

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

per Jonasch, Eric, Walker, Cheryl Lyn, Rathmell, W. Kimryn
Publicat a Nat Rev Nephrol (2020)